MOORGATE LIMITED
Company number 02526321 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: MOORGATE LIMITED
1. Financial Health Score: C+
Explanation: Moorgate Limited exhibits symptoms of chronic leverage dependency alongside a fragile equity base. While the company has survived for over three decades—a testament to its resilience—its financial structure shows significant strain. The debt-to-equity ratio of approximately 6.3:1 is a critical concern, and the substantial increase in long-term liabilities raises questions about sustainability. However, positive net current assets and consistent trading history provide some comfort.
2. Key Vital Signs
| Vital Sign | Reading | Interpretation |
|---|---|---|
| Net Assets | £32,146 (2025) | Down from £35,446 (2024) — a £3,300 decline indicating a small loss for the year |
| Total Liabilities | £202,158 | 6.3x the equity base — critically high leverage |
| Long-term Debt | £152,956 | Up 61% from £95,079 — significant and concerning increase |
| Net Current Assets | £171,298 | Appears healthy, but inflated by £113,943 in prepayments |
| Current Ratio | 4.48x | Surface-level liquidity appears strong |
| Fixed Assets | £13,864 | Declining — minimal reinvestment in the business |
| Share Capital | £1,000 | Thin capitalisation; retained profits form nearly all equity |
Trend Analysis: Net Assets Over 10 Years
| Year | Net Assets | Year-on-Year Change |
|---|---|---|
| 2016 | £17,824 | — |
| 2017 | £18,864 | +£1,040 |
| 2018 | £33,207 | +£14,343 |
| 2019 | £42,122 | +£8,915 |
| 2020 | £8,009 | -£34,113 ⚠️ |
| 2021 | £18,069 | +£10,060 |
| 2022 | £28,398 | +£10,329 |
| 2023 | £30,332 | +£1,934 |
| 2024 | £35,446 | +£5,114 |
| 2025 | £32,146 | -£3,300 ⚠️ |
3. Diagnosis
Primary Condition: Chronic Over-Leverage with Questionable Asset Quality
The financial data reveals three interconnected conditions:
a) The Debt Tumour — Growing Long-Term Liabilities
Long-term creditors have surged from £95,079 to £152,956 — a £57,877 increase (61%) in a single year. This now represents approximately 76% of total liabilities and 4.8x the entire equity base. For a micro-entity with only 3 employees, this level of long-term debt is disproportionate. This may represent director loans (common in family companies), bank borrowing, or deferred consideration — but without fuller accounts, the nature and terms remain opaque.
b) The Phantom Assets — Prepayments and Accrued Income
The balance sheet carries £113,943 in prepayments and accrued income — representing 48.6% of total assets. This is an unusually large figure for a computer equipment dealer. If these prepayments are not fully recoverable (e.g., deposits with suppliers who fail, or accrued income that proves irrecoverable), the equity position could deteriorate rapidly. Stripping out these prepayments from the asset base would reduce effective net assets to just £18,203 — a dangerously thin cushion.
c) The Wasting Asset Base — Declining Fixed Assets
Fixed assets have declined from £15,533 to £13,864, suggesting minimal capital reinvestment. For a company that has traded for 34 years, this indicates the business may be running on legacy assets without refreshing its infrastructure — a potential sign that the business is being managed on a "run-off" basis.
Positive Indicators
- Strong short-term liquidity: The current ratio of 4.48x suggests no immediate cash crisis
- Long trading history: 34 years of operation demonstrates adaptability
- Compliance health: Filing is up to date, no director disqualifications
- Net assets recovery since 2020: Equity has rebuilt from the £8,009 low point
Red Flags
- Debt-to-equity ratio of 6.3:1 — well above healthy thresholds (typically <2:1)
- Equity erosion in 2025 — the small loss reverses the recovery trend
- Opaque micro-entity accounts — limited disclosure prevents full diagnosis
- Family control with minimal external oversight — both directors are PSCs with 25-50% ownership
4. Recommendations
Immediate Actions (Within 3 Months)
-
Investigate the Long-Term Debt Composition - Determine whether the £152,956 represents director loans, bank debt, or trade creditors - If director loans, consider formalising terms and potentially converting to equity to strengthen the balance sheet - If bank debt, review interest terms and repayment schedules for sustainability
-
Audit Prepayment Recoverability - The £113,943 in prepayments and accrued income requires scrutiny - Assess whether these represent genuine recoverable amounts or whether impairment provisions are needed - Request detailed schedules from management
-
Cash Flow Forecasting - Given the thin equity base and high leverage, prepare 12-month cash flow projections - Model scenarios: What happens if a major customer defaults or if long-term debt is called?
Medium-Term Actions (3-12 Months)
-
Deleveraging Strategy - Target a reduction in long-term debt to bring debt-to-equity below 3:1 - Consider whether profits can be retained rather than distributed to accelerate debt reduction - If director loans exist, explore converting them to equity to improve the balance sheet optics
-
Capital Investment Review - The declining fixed asset base suggests the business may need reinvestment to remain competitive - Prepare a business case for any necessary asset purchases, considering the impact on an already-geared balance sheet
-
Consider Upgrading from Micro-Entity Reporting - Filing as a micro-entity provides minimal transparency to stakeholders - Voluntarily filing fuller accounts would improve credibility with lenders, suppliers, and potential partners - This is particularly important given the high leverage — creditors deserve greater visibility
Long-Term Strategic Considerations
-
Succession and Business Continuity - The company is controlled by two individuals (James and Gillian Hennessy) - At some point, succession or exit planning will be necessary - The current thin equity base and high debt may complicate any sale or transition
-
Profitability Focus - The 2025 loss, however small, must be reversed - Review pricing, margins, and cost structure to ensure the business generates sufficient profit to service its debt and rebuild equity
Prognosis
Cautiously Stable with Significant Risk Factors
The company is not in immediate danger — short-term liquidity is adequate and the business has demonstrated remarkable longevity. However, the financial structure is akin to a patient with chronic high blood pressure: they may continue functioning for years, but the condition creates vulnerability to any shock. The £152,956 in long-term debt against £32,146 in equity means that even a moderate deterioration in trading could push the company into negative net assets territory. The 2025 loss, though small, is a warning sign that the recovery since 2020 may be stalling.
If the long-term debt is primarily director loans (which is plausible given the family ownership structure), the risk profile is somewhat lower than the raw numbers suggest, as such loans are typically more patient capital. However, this assumption requires verification.